Alternative treatments for focal and segmental glomerular sclerosis

Clinical Nephrology

Volumn 55, Issue 5, 2001, Pages 345-348

  Ponticelli, C ^a   Passerini, P ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Corticosteroids; Cyclosporine; Cytotoxic agents; Focal glomerulosclerosis

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; CYTOTOXIC AGENT; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PRAVASTATIN; PREDNISONE; STEROID; TACROLIMUS; WARFARIN;

APHERESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GLOMERULOSCLEROSIS; HUMAN; IMMUNOADSORPTION; MULTICENTER STUDY; PLASMAPHERESIS; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; REMISSION; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME;

GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PLASMAPHERESIS;

EID: 0035005011     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children
2. Mycophenolate mofetil (MMF) in steroid-resistant focal segmental glomerulosclerosis (FSGS) (cyclosporine-dependent or resistant)
3. Aggressive treatment of severe idiopathic focal segmental glomerulosclerosis
4. The impact of prolonged immunosuppression on the outcome of idiopathic focal segmental glomerulosclerosis with nephrotic syndrome in adults
5. The use of mycophenolate mofetil in children with nephrotic syndrome
6. Lipophresis in the nephrotic syndrome
7. Management of focal segmental glomerulosclerosis: Evidence-based recommendations
8. Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids
9. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis
10. Effect of plasma protein adsorption on protein excretion in kidney transplant recipients with recurrent nephrotic syndrome
11. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys
12. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases
13. Pulse steroid therapy (PTS) does not alter the course of focal segmental glomerulosclerosis (FSGS)
14. Plasma immuoadsorption treatment in patients with primary focal and segmental glomerulosclerosis
15. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis
16. Primary focal segmental glomerulosclerosis: Clinical course and response to therapy
17. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children
18. Treatment of focal segmental glomerulosclerosis
19. Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome
20. Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents
21. Long-term renal tolerance of cyclosporine A treatment in adult idiopathic nephrotic syndrome
22. Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: Minimal-change disease and focal segmental glomerulosclerosis
23. Adding plasmapheresis to corticosteroids and alkylating agents: Does it benefit patients with focal segmental glomerulosclerosis?
24. Mycophenolate mofetil (MMF) treatment in steroid-resistant relapsing nephrotic syndrome (NS) of childhood
25. Low-density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome
26. Evidence suggesting undertreatment in adults with idiopathic focal segmental glomerulosclerosis
27. Focal and segmental glomerulosclerosis
28. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome
29. The place of cyclosporin in the management of primary nephrotic syndrome
30. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?
31. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis
32. Efficacy and safety of tacrolimus + steroid in patients with cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis
33. "The FSGS factor": Enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma
34. Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children
35. Cyclosporine A-induced remission of relapsing nephrotic syndrome in children
36. Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: A long-term follow-up
37. Methyl-prednisolone treatment of patients with steroid-resistant nephrotic
38. The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with cyclosporin